GlassScriptPhysician profile
Anthony S Cohen
NPI 1154308732
$7,929.34
in general payments reported to CMS, 2019-2025
58 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,561 · 2020: $266 · 2021: $1,506 · 2022: $1,815 · 2023: $1,688 · 2024: $985 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,781.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,781.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,464.40 | 2021-2025 | Ubrelvy, Qulipta |
| Biogen, INC. | $874.54 | 2019-2024 | Tysabri, Vumerity |
| Neurocrine Biosciences, INC. | $488.44 | 2019-2023 | Ongentys, Ingrezza |
| Emd Serono, INC. | $365.24 | 2019-2023 | Mavenclad |
| Sk Life Science, INC. | $360.96 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $277.63 | 2021-2024 | Hyqvia, Gammagard Liquid |
| Lilly USA, LLC | $276.68 | 2019-2024 | Amyvid, Reyvow, Emgality |
| Novartis Pharmaceuticals Corporation | $264.51 | 2019-2024 | |
| Lundbeck LLC | $240.52 | 2019-2024 | Vyepti, Rexulti |
| Alexion Pharmaceuticals, INC. | $213.84 | 2019-2024 | Ultomiris |
| Genzyme Corporation | $172.48 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $145.72 | 2019-2020 | |
| Pfizer INC. | $145.55 | 2023-2024 | |
| Acadia Pharmaceuticals INC | $139.06 | 2019-2023 | Nuplazid |
| Mdd US Operations, LLC | $138.69 | 2019-2023 | Gocovri |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.